Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozurdex in Anterior Uveitis
NCT00333996Phase 3Terminated
- Sponsor
- Allergan
- Start
- May 2006
- Primary completion
- Mar 2007
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ozurdex in anterior uveitis (AU), sponsored by Allergan. Started May 2006; status: terminated.
02
Drugs
ozurdex
03
Conditions
anterior uveitis (AU)
Beyond the preview
Go deeper on NCT00333996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00333996.